Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 147

1.

Pharmacological inhibition of S-nitrosoglutathione reductase improves endothelial vasodilatory function in rats in vivo.

Chen Q, Sievers RE, Varga M, Kharait S, Haddad DJ, Patton AK, Delany CS, Mutka SC, Blonder JP, Dubé GP, Rosenthal GJ, Springer ML.

J Appl Physiol (1985). 2013 Mar 15;114(6):752-60. doi: 10.1152/japplphysiol.01302.2012. Epub 2013 Jan 24.

2.

Nicorandil prevents endothelial dysfunction due to antioxidative effects via normalisation of NADPH oxidase and nitric oxide synthase in streptozotocin diabetic rats.

Serizawa K, Yogo K, Aizawa K, Tashiro Y, Ishizuka N.

Cardiovasc Diabetol. 2011 Nov 23;10:105. doi: 10.1186/1475-2840-10-105.

3.
4.

Nebivolol Acts as a S-Nitrosoglutathione Reductase Inhibitor: A New Mechanism of Action.

Jiang H, Polhemus DJ, Islam KN, Torregrossa AC, Li Z, Potts A, Lefer DJ, Bryan NS.

J Cardiovasc Pharmacol Ther. 2016 Sep;21(5):478-85. doi: 10.1177/1074248415626300. Epub 2016 Jan 8.

PMID:
26746429
5.

Vasorelaxing and antihypertensive effects of 7,8-dihydroxyflavone.

Huai R, Han X, Wang B, Li C, Niu Y, Li R, Qu Z.

Am J Hypertens. 2014 May;27(5):750-60. doi: 10.1093/ajh/hpt220. Epub 2013 Dec 6.

PMID:
24317273
6.

Vasodilatory activity and antihypertensive profile mediated by inhibition of phosphodiesterase type 1 induced by a novel sulfonamide compound.

Pontes LB, Antunes F, Sudo RT, Raimundo JM, Lima LM, Barreiro EJ, Zapata-Sudo G.

Fundam Clin Pharmacol. 2012 Dec;26(6):690-700. doi: 10.1111/j.1472-8206.2011.00999.x. Epub 2011 Nov 9.

PMID:
22066694
7.

Epoetin beta pegol ameliorates flow-mediated dilation with improving endothelial nitric oxide synthase coupling state in nonobese diabetic rats.

Serizawa K, Yogo K, Tashiro Y, Kawasaki R, Endo K, Shimonaka Y, Hirata M.

Cardiovasc Ther. 2017 Apr;35(2). doi: 10.1111/1755-5922.12250.

8.

Heme oxygenase-derived carbon monoxide promotes arteriolar endothelial dysfunction and contributes to salt-induced hypertension in Dahl salt-sensitive rats.

Teran FJ, Johnson RA, Stevenson BK, Peyton KJ, Jackson KE, Appleton SD, Durante W, Johnson FK.

Am J Physiol Regul Integr Comp Physiol. 2005 Mar;288(3):R615-22. Epub 2004 Nov 4.

9.

Contribution of insulin and Akt1 signaling to endothelial nitric oxide synthase in the regulation of endothelial function and blood pressure.

Symons JD, McMillin SL, Riehle C, Tanner J, Palionyte M, Hillas E, Jones D, Cooksey RC, Birnbaum MJ, McClain DA, Zhang QJ, Gale D, Wilson LJ, Abel ED.

Circ Res. 2009 May 8;104(9):1085-94. doi: 10.1161/CIRCRESAHA.108.189316. Epub 2009 Apr 2.

10.

Febuxostat, a novel xanthine oxidoreductase inhibitor, improves hypertension and endothelial dysfunction in spontaneously hypertensive rats.

Shirakura T, Nomura J, Matsui C, Kobayashi T, Tamura M, Masuzaki H.

Naunyn Schmiedebergs Arch Pharmacol. 2016 Aug;389(8):831-8. doi: 10.1007/s00210-016-1239-1. Epub 2016 May 20.

11.

Cardiovascular effects of arginase inhibition in spontaneously hypertensive rats with fully developed hypertension.

Bagnost T, Ma L, da Silva RF, Rezakhaniha R, Houdayer C, Stergiopulos N, André C, Guillaume Y, Berthelot A, Demougeot C.

Cardiovasc Res. 2010 Aug 1;87(3):569-77. doi: 10.1093/cvr/cvq081. Epub 2010 Mar 10.

PMID:
20219858
12.

Dahl SS rats demonstrate enhanced aortic perivascular adipose tissue-mediated buffering of vasoconstriction through activation of NOS in the endothelium.

Spradley FT, Ho DH, Pollock JS.

Am J Physiol Regul Integr Comp Physiol. 2016 Feb 1;310(3):R286-96. doi: 10.1152/ajpregu.00469.2014. Epub 2015 Nov 25.

13.

Impaired endothelium-dependent relaxation in mesenteric arteries of reduced renal mass hypertensive rats.

Kimura K, Nishio I.

Scand J Clin Lab Invest. 1999 May;59(3):199-204.

PMID:
10400164
14.

Role of angiotensin II and oxidative stress in vascular insulin resistance linked to hypertension.

Zhou MS, Schulman IH, Raij L.

Am J Physiol Heart Circ Physiol. 2009 Mar;296(3):H833-9. doi: 10.1152/ajpheart.01096.2008. Epub 2009 Jan 16.

15.

Endothelial nitric oxide synthase enhancer reduces oxidative stress and restores endothelial function in db/db mice.

Cheang WS, Wong WT, Tian XY, Yang Q, Lee HK, He GW, Yao X, Huang Y.

Cardiovasc Res. 2011 Nov 1;92(2):267-75. doi: 10.1093/cvr/cvr233. Epub 2011 Aug 29.

PMID:
21875904
16.

The effects of amlodipine and S(-)-amlodipine on vascular endothelial function in patients with hypertension.

He Y, Si D, Yang C, Ni L, Li B, Ding M, Yang P.

Am J Hypertens. 2014 Jan;27(1):27-31. doi: 10.1093/ajh/hpt138. Epub 2013 Aug 19.

PMID:
23959544
17.

In vivo human lower extremity saphenous vein bypass grafts manifest flow mediated vasodilation.

Owens CD, Wake N, Conte MS, Gerhard-Herman M, Beckman JA.

J Vasc Surg. 2009 Nov;50(5):1063-70. doi: 10.1016/j.jvs.2009.06.022. Epub 2009 Aug 12.

18.

The effect of insulin to decrease neointimal growth after arterial injury is endothelial nitric oxide synthase-dependent.

Guo J, Breen DM, Pereira TJ, Dalvi PS, Zhang H, Mori Y, Ghanim H, Tumiati L, Fantus IG, Bendeck MP, Dandona P, Rao V, Dolinsky VW, Heximer SP, Giacca A.

Atherosclerosis. 2015 Jul;241(1):111-20. doi: 10.1016/j.atherosclerosis.2015.04.799. Epub 2015 Apr 25.

PMID:
25974101
19.

Roles of endothelial oxidases in endothelium-derived hyperpolarizing factor responses in mice.

Takaki A, Morikawa K, Murayama Y, Yamagishi H, Hosoya M, Ohashi J, Shimokawa H.

J Cardiovasc Pharmacol. 2008 Dec;52(6):510-7. doi: 10.1097/FJC.0b013e318190358b.

PMID:
19034034
20.

The anti-hypertensive effect of Danshen (Salvia miltiorrhiza) and Gegen (Pueraria lobata) formula in rats and its underlying mechanisms of vasorelaxation.

Ng CF, Koon CM, Cheung DW, Lam MY, Leung PC, Lau CB, Fung KP.

J Ethnopharmacol. 2011 Oct 11;137(3):1366-72. doi: 10.1016/j.jep.2011.08.006. Epub 2011 Aug 9.

PMID:
21855622

Supplemental Content

Support Center